相关实验视频
Updated: Jan 7, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
血小板缺乏与过程和临床结果的关联
Hayley B Gershengorn1,2, Yanyun Wu3, Andrea Carlotto4
1Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.
一个勒索软件事件导致短缺期间血小板输血减少,特别是对于数量在10,000-49,000/μL之间的患者. 这种实践变化发生在没有对患者造成重大伤害的情况下,这表明减少浪费的潜力,同时保持护理质量.
科学领域:
- 血液学 血液学 血液学
- 输血医学 输血医学
- 卫生系统研究 卫生系统研究
背景情况:
- 血小板短缺会影响患者的护理,但数据有限.
- 南佛罗里达州的一次勒索软件事件创造了一个自然实验,以研究血小板短缺的影响.
研究的目的:
- 评估血小板短缺对输血实践和患者结果的影响.
- 评估在短缺期间减少输血是否会导致不良事件.
主要方法:
- 迈阿密大学医院和诊所对成人住院的回顾性研究.
- 在短缺期间,短缺前和短缺后分析血小板计数 (<10,000/μL,10,000-49,000/μL,≥50,000/μL).
- 输血率,医院死亡率和出血的比较.
主要成果:
- 在短缺期间,对于血小板数量为10,000-49,000/μL的患者,与短缺前后相比,输血的数量较少.
- 在不同时期内,没有观察到医院死亡率或出血的显著差异.
- 数字上较高的死亡率和较低的出血率在10,000-49,000/μL组的短缺期间被注意到.
结论:
- 血小板短缺条件导致中等血小板计数的输血减少,而不会对患者造成重大伤害.
- 研究结果表明,实践变化是可能的快速和符合指导方针的护理可以减少浪费,同时保持质量.
- 这项研究强调了优化血小板输血策略的潜力.
更多相关视频
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
相关概念视频
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins